Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder.

PubWeight™: 1.54‹?› | Rank: Top 4%

🔗 View Article (PMC 2681000)

Published in Am J Hum Genet on April 30, 2009

Authors

Regina Waltes1, Reinhard Kalb, Magtouf Gatei, Amanda W Kijas, Markus Stumm, Alexandra Sobeck, Britta Wieland, Raymonda Varon, Yaniv Lerenthal, Martin F Lavin, Detlev Schindler, Thilo Dörk

Author Affiliations

1: Clinics of Obstetrics and Gynaecology, Hannover Medical School, D-30625 Hannover, Germany.

Articles citing this

The DNA damage response: making it safe to play with knives. Mol Cell (2010) 16.13

The MRE11 complex: starting from the ends. Nat Rev Mol Cell Biol (2011) 3.83

Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet (2010) 3.57

DNA resection in eukaryotes: deciding how to fix the break. Nat Struct Mol Biol (2010) 2.81

Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks. DNA Repair (Amst) (2010) 1.96

ABC ATPase signature helices in Rad50 link nucleotide state to Mre11 interface for DNA repair. Nat Struct Mol Biol (2011) 1.66

The MRN complex in double-strand break repair and telomere maintenance. FEBS Lett (2010) 1.53

Genetic causes of microcephaly and lessons for neuronal development. Wiley Interdiscip Rev Dev Biol (2012) 1.34

A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination. Mol Cell (2015) 1.27

Nijmegen breakage syndrome (NBS). Orphanet J Rare Dis (2012) 1.27

Correct end use during end joining of multiple chromosomal double strand breaks is influenced by repair protein RAD50, DNA-dependent protein kinase DNA-PKcs, and transcription context. J Biol Chem (2011) 1.23

ATP driven structural changes of the bacterial Mre11:Rad50 catalytic head complex. Nucleic Acids Res (2011) 1.19

Pathogenesis of ataxia-telangiectasia: the next generation of ATM functions. Blood (2013) 1.18

Structure of Mre11-Nbs1 complex yields insights into ataxia-telangiectasia-like disease mutations and DNA damage signaling. Nat Struct Mol Biol (2012) 1.14

The ATM signaling network in development and disease. Front Genet (2013) 1.09

Autophosphorylation and ATM activation: additional sites add to the complexity. J Biol Chem (2010) 1.07

Chemotherapeutic compounds targeting the DNA double-strand break repair pathways: the good, the bad, and the promising. Front Oncol (2014) 1.06

Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study. Breast Cancer Res (2014) 1.00

DNA double-strand break signaling and human disorders. Genome Integr (2010) 1.00

Hereditary breast cancer: ever more pieces to the polygenic puzzle. Hered Cancer Clin Pract (2013) 0.99

ATM protein-dependent phosphorylation of Rad50 protein regulates DNA repair and cell cycle control. J Biol Chem (2011) 0.98

Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE study. Hum Mutat (2011) 0.98

Genetics and genomics of radiotherapy toxicity: towards prediction. Genome Med (2011) 0.95

Diseases associated with defective responses to DNA damage. Cold Spring Harb Perspect Biol (2012) 0.94

Dynamics of p53 and NF-κB regulation in response to DNA damage and identification of target proteins suitable for therapeutic intervention. BMC Syst Biol (2012) 0.94

Germline variants in MRE11/RAD50/NBN complex genes in childhood leukemia. BMC Cancer (2013) 0.91

R-loops in proliferating cells but not in the brain: implications for AOA2 and other autosomal recessive ataxias. PLoS One (2014) 0.90

Visualization of local DNA unwinding by Mre11/Rad50/Nbs1 using single-molecule FRET. Proc Natl Acad Sci U S A (2013) 0.89

Mechanism and regulation of DNA end resection in eukaryotes. Crit Rev Biochem Mol Biol (2016) 0.88

DNA Damage Signalling and Repair Inhibitors: The Long-Sought-After Achilles' Heel of Cancer. Biomolecules (2015) 0.88

ATM-Dependent Phosphorylation of All Three Members of the MRN Complex: From Sensor to Adaptor. Biomolecules (2015) 0.86

Primary immunodeficiency diseases associated with neurologic manifestations. J Clin Immunol (2011) 0.86

DNA replication stress: from molecular mechanisms to human disease. Chromosoma (2016) 0.84

The MRN complex is transcriptionally regulated by MYCN during neural cell proliferation to control replication stress. Cell Death Differ (2015) 0.84

ATP-dependent DNA binding, unwinding, and resection by the Mre11/Rad50 complex. EMBO J (2015) 0.83

Regulation of DNA damage responses and cell cycle progression by hMOB2. Cell Signal (2014) 0.82

The Mre11/Rad50/Nbs1 complex: recent insights into catalytic activities and ATP-driven conformational changes. Exp Cell Res (2014) 0.82

Functional analyses of ATM, ATR and Fanconi anemia proteins in lung carcinoma : ATM, ATR and FA in lung carcinoma. BMC Cancer (2015) 0.81

Mre11 ATLD17/18 mutation retains Tel1/ATM activity but blocks DNA double-strand break repair. Nucleic Acids Res (2012) 0.81

ATM-dependent phosphorylation of MRE11 controls extent of resection during homology directed repair by signalling through Exonuclease 1. Nucleic Acids Res (2015) 0.80

The MRN-CtIP pathway is required for metaphase chromosome alignment. Mol Cell (2013) 0.79

MRNIP/C5orf45 Interacts with the MRN Complex and Contributes to the DNA Damage Response. Cell Rep (2016) 0.78

Structural studies of DNA end detection and resection in homologous recombination. Cold Spring Harb Perspect Biol (2014) 0.78

Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer. Gynecol Oncol (2016) 0.77

Low cytoplasmic and nuclear KPNA2 expression in radiotherapy-treated head and neck squamous cell cancer is associated with an adverse outcome. Int J Clin Exp Pathol (2015) 0.77

A patient with polymerase E1 deficiency (POLE1): clinical features and overlap with DNA breakage/instability syndromes. BMC Med Genet (2015) 0.77

Programmed DNA breaks in lymphoid cells: repair mechanisms and consequences in human disease. Immunology (2015) 0.76

DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition. Am J Cancer Res (2015) 0.76

The Mre11-Nbs1 Interface Is Essential for Viability and Tumor Suppression. Cell Rep (2017) 0.75

Sharpening the ends for repair: mechanisms and regulation of DNA resection. Acta Biochim Biophys Sin (Shanghai) (2016) 0.75

Homozygous mutation of MTPAP causes cellular radiosensitivity and persistent DNA double-strand breaks. Cell Death Dis (2014) 0.75

Chronic oxidative damage together with genome repair deficiency in the neurons is a double whammy for neurodegeneration: Is damage response signaling a potential therapeutic target? Mech Ageing Dev (2016) 0.75

Nijmegen Breakage Syndrome fibroblasts and iPSCs: cellular models for uncovering disease-associated signaling pathways and establishing a screening platform for anti-oxidants. Sci Rep (2017) 0.75

Mechanisms of DNA-protein crosslink repair. Nat Rev Mol Cell Biol (2017) 0.75

Articles cited by this

Extension of life-span by introduction of telomerase into normal human cells. Science (1998) 20.48

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature (2003) 20.13

ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer (2003) 16.06

A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science (1995) 15.20

The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell (1998) 6.58

The 3' to 5' exonuclease activity of Mre 11 facilitates repair of DNA double-strand breaks. Mol Cell (1998) 6.50

Requirement of the MRN complex for ATM activation by DNA damage. EMBO J (2003) 6.23

A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome. Nat Genet (2003) 6.03

The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell (1999) 5.44

Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell (1998) 4.72

Radiosensitivity in ataxia-telangiectasia: a new explanation. Proc Natl Acad Sci U S A (1980) 4.64

Roles of ATM and NBS1 in chromatin structure modulation and DNA double-strand break repair. Nat Cell Biol (2007) 4.14

hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks. Mol Cell Biol (1997) 4.11

Nbs1 potentiates ATP-driven DNA unwinding and endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev (1999) 4.08

DNA damage-dependent nuclear dynamics of the Mre11 complex. Mol Cell Biol (2001) 3.78

Phosphorylation of SMC1 is a critical downstream event in the ATM-NBS1-BRCA1 pathway. Genes Dev (2004) 3.76

Human Rad50/Mre11 is a flexible complex that can tether DNA ends. Mol Cell (2001) 3.66

Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat Cell Biol (2005) 3.44

Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin template. Biochem Cell Biol (2007) 3.13

Mesoscale conformational changes in the DNA-repair complex Rad50/Mre11/Nbs1 upon binding DNA. Nature (2005) 3.09

Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Nat Genet (2007) 3.08

Disruption of mRad50 causes embryonic stem cell lethality, abnormal embryonic development, and sensitivity to ionizing radiation. Proc Natl Acad Sci U S A (1999) 3.06

Mre11 complex and DNA replication: linkage to E2F and sites of DNA synthesis. Mol Cell Biol (2001) 2.85

DNA strand break repair and human genetic disease. Annu Rev Genomics Hum Genet (2007) 2.80

Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr Biol (2001) 2.72

Detecting polymorphisms and mutations in candidate genes. Am J Hum Genet (2002) 2.70

High resolution visual mapping of stretched DNA by fluorescent hybridization. Nat Genet (1993) 2.51

DNA replication-dependent nuclear dynamics of the Mre11 complex. Mol Cancer Res (2003) 2.23

ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene (2007) 2.12

The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep (2003) 1.97

Nbs1 is required for ATR-dependent phosphorylation events. EMBO J (2004) 1.95

Involvement of novel autophosphorylation sites in ATM activation. EMBO J (2006) 1.94

DNA double labelling with IdUrd and CldUrd for spatial and temporal analysis of cell proliferation and DNA replication. Histochem J (1992) 1.75

Distinct functional domains of nibrin mediate Mre11 binding, focus formation, and nuclear localization. Mol Cell Biol (2001) 1.73

The mammalian Mre11-Rad50-nbs1 protein complex: integration of functions in the cellular DNA-damage response. Am J Hum Genet (1999) 1.73

DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture. Mol Cancer Res (2008) 1.69

The Mre11/Rad50/Nbs1 complex and its role as a DNA double-strand break sensor for ATM. Cell Cycle (2005) 1.67

Effect of ionizing radiation on DNA synthesis in ataxia telangiectasia cells. Nucleic Acids Res (1980) 1.62

Radiosensitivity in ataxia-telangiectasia: anomalies in radiation-induced cell cycle delay. Int J Radiat Biol (1994) 1.61

Nijmegen breakage syndrome. J Med Genet (1996) 1.58

Rapid activation of ATM on DNA flanking double-strand breaks. Nat Cell Biol (2007) 1.49

High frequencies of inversions and translocations of chromosomes 7 and 14 in ataxia telangiectasia. Mutat Res (1980) 1.38

The Drosophila Mre11/Rad50 complex is required to prevent both telomeric fusion and chromosome breakage. Curr Biol (2004) 1.38

Rad50 depletion impacts upon ATR-dependent DNA damage responses. Hum Mol Genet (2005) 1.36

Conditional deletion of Nbs1 in murine cells reveals its role in branching repair pathways of DNA double-strand breaks. EMBO J (2006) 1.36

Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Genes Dev (2009) 1.36

Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst) (2004) 1.33

NBS1 and its functional role in the DNA damage response. DNA Repair (Amst) (2004) 1.30

Identification of ataxia telangiectasia heterozygotes, a cancer prone population. Nature (1978) 1.30

Active role for nibrin in the kinetics of atm activation. Mol Cell Biol (2006) 1.27

Chromosome instability and X-ray hypersensitivity in a microcephalic and growth-retarded child. Am J Med Genet (1991) 1.24

The involvement of DNA-damage and -repair defects in neurological dysfunction. Am J Hum Genet (2008) 1.17

Spontaneous cytogenetic abnormalities in lymphocytes from thirteen patients with ataxia telangiectasia. Int J Cancer (1981) 1.06

Cellular and clinical impact of haploinsufficiency for genes involved in ATR signaling. Am J Hum Genet (2007) 1.06

RAD50 and NBS1 form a stable complex functional in DNA binding and tethering. Nucleic Acids Res (2009) 1.05

High frequency of spontaneous translocations revealed by FISH in cells from patients with the cancer-prone syndromes ataxia telangiectasia and Nijmegen breakage syndrome. Cytogenet Cell Genet (2001) 0.98

Double strand break metabolism and cancer susceptibility: lessons from the mre11 complex. Cell Cycle (2004) 0.85

Simultaneous measurement, using flow cytometry, of radiosensitivity and defective mitogen response in ataxia telangiectasia and related syndromes. Eur J Pediatr (1992) 0.84

Ataxia telangiectasia: an anomaly in DNA replication after irradiation. Nucleic Acids Res (1981) 0.78

A Maxwell's Demon type of membrane transport: possibility for active transport by ABC-type transporters? J Theor Biol (2002) 0.77

Articles by these authors

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science (2007) 20.11

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30

Requirement of the MRN complex for ATM activation by DNA damage. EMBO J (2003) 6.23

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat Genet (2010) 5.48

ATM activation by oxidative stress. Science (2010) 5.22

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer. Nat Genet (2006) 5.12

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat Genet (2005) 4.13

Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Science (2008) 4.04

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype. Nat Genet (2011) 3.74

Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat Genet (2010) 3.57

Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst (2002) 3.46

GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42

Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20

Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. EMBO J (2004) 3.20

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07

Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev (2008) 3.05

Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. J Natl Cancer Inst (2009) 2.88

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72

Ataxia telangiectasia mutated (ATM) is essential for DNA-PKcs phosphorylations at the Thr-2609 cluster upon DNA double strand break. J Biol Chem (2006) 2.66

BLAP75, an essential component of Bloom's syndrome protein complexes that maintain genome integrity. EMBO J (2005) 2.60

Identification of the Fanconi anemia complementation group I gene, FANCI. Cell Oncol (2007) 2.50

A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Mol Cell (2010) 2.36

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24

Proapoptotic BID is an ATM effector in the DNA-damage response. Cell (2005) 2.21

Nonsense mutation p.Q548X in BLM, the gene mutated in Bloom's syndrome, is associated with breast cancer in Slavic populations. Breast Cancer Res Treat (2012) 2.19

Requirement of ATM-dependent monoubiquitylation of histone H2B for timely repair of DNA double-strand breaks. Mol Cell (2011) 2.16

Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia. Am J Hum Genet (2013) 2.15

Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nat Genet (2002) 2.11

The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09

FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway. EMBO J (2007) 2.00

RMI, a new OB-fold complex essential for Bloom syndrome protein to maintain genome stability. Genes Dev (2008) 1.97

Seckel syndrome exhibits cellular features demonstrating defects in the ATR-signalling pathway. Hum Mol Genet (2004) 1.95

Involvement of novel autophosphorylation sites in ATM activation. EMBO J (2006) 1.94

Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88

Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents. J Biol Chem (2007) 1.80

Functional consequences of ATM sequence variants for chromosomal radiosensitivity. Genes Chromosomes Cancer (2004) 1.76

A new type of mutation causes a splicing defect in ATM. Nat Genet (2002) 1.74

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73

Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype. Am J Hum Genet (2007) 1.67

Histone H2AX and Fanconi anemia FANCD2 function in the same pathway to maintain chromosome stability. EMBO J (2007) 1.65

Genotype-phenotype correlations in Fanconi anemia. Mutat Res (2009) 1.65

Deficiency in the catalytic subunit of DNA-dependent protein kinase causes down-regulation of ATM. Cancer Res (2005) 1.65

Involvement of the nuclear proteasome activator PA28γ in the cellular response to DNA double-strand breaks. Cell Cycle (2011) 1.63

Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations. PLoS Genet (2010) 1.62

Aprataxin, a novel protein that protects against genotoxic stress. Hum Mol Genet (2004) 1.60

Exclusion of the C/D box snoRNA gene cluster HBII-52 from a major role in Prader-Willi syndrome. Hum Genet (2004) 1.60

Senataxin, defective in ataxia oculomotor apraxia type 2, is involved in the defense against oxidative DNA damage. J Cell Biol (2007) 1.59

Association of ESR1 gene tagging SNPs with breast cancer risk. Hum Mol Genet (2009) 1.58

Small supernumerary marker chromosomes (SMCs): genotype-phenotype correlation and classification. Hum Genet (2003) 1.57

Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56

Nonclassical splicing mutations in the coding and noncoding regions of the ATM Gene: maximum entropy estimates of splice junction strengths. Hum Mutat (2004) 1.53

A rapid method for retrovirus-mediated identification of complementation groups in Fanconi anemia patients. Mol Ther (2005) 1.48

Delayed diagnosis and complications of Fanconi anaemia at advanced age--a paradigm. Br J Haematol (2006) 1.48

Venom factor V from the common brown snake escapes hemostatic regulation through procoagulant adaptations. Blood (2009) 1.48

Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle (2010) 1.48

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47

Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. J Biol Chem (2002) 1.44

Warsaw breakage syndrome, a cohesinopathy associated with mutations in the XPD helicase family member DDX11/ChlR1. Am J Hum Genet (2010) 1.42

Functional link between BLM defective in Bloom's syndrome and the ataxia-telangiectasia-mutated protein, ATM. J Biol Chem (2002) 1.41

Cellular radiosensitivity: how much better do we understand it? Int J Radiat Biol (2009) 1.40

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39

Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun (2013) 1.36

A novel approach to describe a U1 snRNA binding site. Nucleic Acids Res (2003) 1.35

A novel mutation in GJA8 associated with jellyfish-like cataract in a family of Indian origin. Mol Vis (2008) 1.34

IGF-1 phosphorylates AMPK-alpha subunit in ATM-dependent and LKB1-independent manner. Biochem Biophys Res Commun (2004) 1.34

Identification of human nephron progenitors capable of generation of kidney structures and functional repair of chronic renal disease. EMBO Mol Med (2013) 1.32

Aprataxin, poly-ADP ribose polymerase 1 (PARP-1) and apurinic endonuclease 1 (APE1) function together to protect the genome against oxidative damage. Hum Mol Genet (2009) 1.32

Dissection of a DNA-damage-induced transcriptional network using a combination of microarrays, RNA interference and computational promoter analysis. Genome Biol (2005) 1.31

A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol (2006) 1.31

A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat (2009) 1.30

Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Hum Mol Genet (2009) 1.30

A comprehensive strategy for the subtyping of patients with Fanconi anaemia: conclusions from the Spanish Fanconi Anemia Research Network. J Med Genet (2006) 1.30

Do MDM2 SNP309 and TP53 R72P interact in breast cancer susceptibility? A large pooled series from the breast cancer association consortium. Cancer Res (2007) 1.29

Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.29

CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. J Clin Oncol (2012) 1.29

ATP activates ataxia-telangiectasia mutated (ATM) in vitro. Importance of autophosphorylation. J Biol Chem (2003) 1.27

Immaturity, perinatal inflammation, and retinopathy of prematurity: a multi-hit hypothesis. Early Hum Dev (2009) 1.27

11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26

Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Ann Neurol (2003) 1.26

Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer. Cancer Res (2007) 1.24

Transcriptional modulation induced by ionizing radiation: p53 remains a central player. Mol Oncol (2011) 1.23